A new study suggests GLP-1 class weight-loss drugs may lower cancer risk in people with diabetes. It looked at 170,000 patient records, and found there’s a slightly lower risk of obesity-related cancers in U.S. adults with diabetes who took these popular medications. Katherine Ward has this story and more in Health Matters for Friday May 23, 2025.
Health Matters
Health Matters: GLP-1 drugs may lower cancer risk, study shows
More Videos
-
Health Matters: 4 people hospitalized after Pillsbury Pizza Pops recalled due to E. Coli concerns
-
Health Matters: Pillsbury brand Pizza Pops recalled due to E. coli concerns
-
Health Matters: New regulations targeting illegal drug chemicals, equipment
-
Health Matters: Eli Lilly says new oral pill helps maintain weight loss
-
Flu cases surge across Canada with H3N2 as the dominant strain of the virus
-
Health Matters: Flu season spiking ahead of holiday season, experts say
You are viewing an Accelerated Mobile Webpage.
View Original Article